IL6 and hepatocellular carcinoma: In conclusion, we discovered that the IL-6 promoter methylation level in HBV-associated HCC was significantly lower than that in CHB patients, and the IL-6 mRNA level in HBV-associated HCC was significantly higher than that of CHB patients and normal people.